Our care team stays available for questions, plan updates, and refill coordination for as long as you remain on treatment
There is no single published list of FDA-approved peptides, but the category of formally approved peptide-based drugs includes GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound), insulin analogues, leuprolide, vasopressin analogues, oxytocin, and several others used in endocrinology and oncology
Course Time: from 10.00am 2.30pm Next Available Training Dates: January 19th & 20th February 10rd & 13th March 17th & 19nd April 28th & 29th May 14th & 15th June 9th & 10th However, the date are flexible from Mon-Fri please contact us to arrange your convenient date
Ingredient ratios follow supplier formulation
NICE has approved semaglutide (TA875) and liraglutide (TA664) for managing overweight and obesity in specific patient groups within specialist services, subject to prescribing criteria and monitoring requirements